Skip to content
Riskpilot
← Back to search
Sign in
Get full access
HALEON NORWAY AS
AS
Active
Org 914596947
Lysaker Torg 5, 3. Etasje, 1366
Lysaker
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2014
19 employees
Watchlist
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
HALEON NORWAY AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
AS
Anja Schwarz
Chief Executive Officer
Chief Executive Officer
2018 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SB
Signe Beate Kullmann
Chairman
2023
GV
Georgii Vysots'Ki
Board of Directors
2025
Former (1)
TL
Tobias Løvaas Opsahl
Board of Directors
2023 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unknown
Individual
100%
100%
2022
Haleon Uk Services Limited
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on HALEON NORWAY AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network